| Phase 1/2 | 3 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07140783 | OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in… | Vision Loss Night | Recruiting | 2026-10-14 |
| Phase 1/2 | ||||
| NCT07185256 | Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best… | ARB | Recruiting | 2026-09-24 |
| NCT05616793 | Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal… | LCA5 | Recruiting | 2026-02-19 |
| NCT07681778 | Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited… | Leber Congenital Amaurosis | Not Yet Recruiting | 2026-07-15 |